Tandem Diabetes Care IPO Research Information

Tandem Diabetes Care IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Tandem Diabetes Care, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Tandem Diabetes Care	TNDM - NASDAQ	$13.00-$15.00	$15.00	$19.50	8.0 million	11/14/2013
Underwriter(s): BofA Merrill Lynch, Piper Jaffray
Co-Manager(s): Deutsche Bank Securities, Stifel
Industry: Health Care
Filing(s): Filed 2013-10-07

Tandem Diabetes Care Quote & Chart - Click for current quote - TNDM

About Tandem Diabetes Care (adapted from Tandem Diabetes Care prospectus):
They are a medical device company with an innovative approach to the design, development and commercialization of products for people with insulin-dependent diabetes.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "TNDM" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.